Newbury Pharmaceuticals (Sweden) Market Value
| NEWBRY Stock | 3.44 0.08 2.38% |
| Symbol | Newbury |
Newbury Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Newbury Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Newbury Pharmaceuticals.
| 10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in Newbury Pharmaceuticals on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding Newbury Pharmaceuticals AB or generate 0.0% return on investment in Newbury Pharmaceuticals over 30 days. Newbury Pharmaceuticals is related to or competes with Toleranzia, Gabather. More
Newbury Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Newbury Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Newbury Pharmaceuticals AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.07 | |||
| Information Ratio | (0) | |||
| Maximum Drawdown | 16.73 | |||
| Value At Risk | (4.55) | |||
| Potential Upside | 7.03 |
Newbury Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Newbury Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Newbury Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Newbury Pharmaceuticals historical prices to predict the future Newbury Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0345 | |||
| Jensen Alpha | 0.0479 | |||
| Total Risk Alpha | (0.47) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.2241 |
Newbury Pharmaceuticals Backtested Returns
At this point, Newbury Pharmaceuticals is unstable. Newbury Pharmaceuticals has Sharpe Ratio of 0.0485, which conveys that the firm had a 0.0485% return per unit of risk over the last 3 months. We have found thirty technical indicators for Newbury Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify Newbury Pharmaceuticals' Downside Deviation of 3.07, mean deviation of 2.73, and Risk Adjusted Performance of 0.0345 to check out if the risk estimate we provide is consistent with the expected return of 0.17%. Newbury Pharmaceuticals has a performance score of 3 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.5, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Newbury Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Newbury Pharmaceuticals is expected to be smaller as well. Newbury Pharmaceuticals right now secures a risk of 3.45%. Please verify Newbury Pharmaceuticals AB downside variance, as well as the relationship between the accumulation distribution and market facilitation index , to decide if Newbury Pharmaceuticals AB will be following its current price movements.
Auto-correlation | -0.24 |
Weak reverse predictability
Newbury Pharmaceuticals AB has weak reverse predictability. Overlapping area represents the amount of predictability between Newbury Pharmaceuticals time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Newbury Pharmaceuticals price movement. The serial correlation of -0.24 indicates that over 24.0% of current Newbury Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.24 | |
| Spearman Rank Test | -0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Newbury Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Newbury Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Newbury Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Newbury Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Newbury Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Newbury Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Newbury Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Newbury Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Newbury Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Newbury Pharmaceuticals Lagged Returns
When evaluating Newbury Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Newbury Pharmaceuticals stock have on its future price. Newbury Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Newbury Pharmaceuticals autocorrelation shows the relationship between Newbury Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Newbury Pharmaceuticals AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Newbury Stock
Newbury Pharmaceuticals financial ratios help investors to determine whether Newbury Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Newbury with respect to the benefits of owning Newbury Pharmaceuticals security.